hsuan wei Huang

Dr. hsuan wei Huang

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KWKuan-Han Wu
Kuan-Han Wu
HHhsuan wei Huang
hsuan wei Huang
CLChia Yun Lin
Chia Yun Lin
HHHsu-Tung Huang
Hsu-Tung Huang
FTFan Tzuo-Yau
Fan Tzuo-Yau
KLKuo-Chung Lan
Kuo-Chung Lan
Conventional G-banded karyotyping remains indispensable in prenatal diagnosis but continues to rely on labor-intensive, expertise-dependent visual examination. To address these challenges, we developed a modular artificial intelligence (AI) workflow that automates chromosome interpretation from amniotic fluid metaphase images. The system integrates image denoising, chromosome segmentation, overlap screening, and morphology-based classification, and was trained using 13,223 clinical cases comprising more than 50,000 manually annotated chromosomes. Across training, temporal validation, and independent testing cohorts, classification accuracy remained consistently high (97.45%, 96.95%, and 95.72%, respectively). The overlap-recognition module further reduced downstream errors by reliably identifying composite chromosome regions. When applied to unsorted metaphase images from a later clinical cohort, the workflow successfully generated draft karyotypes without manual sorting and maintained close concordance with expert review. These findings demonstrate that an AI-assisted pipeline can support cytogenetic laboratories by streamlining the most labor-intensive steps of karyotyping, potentially enhancing diagnostic efficiency while preserving interpretive reliability.

3 September 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
YHYu-Yang Hsiao
Yu-Yang Hsiao
HHhsuan wei Huang
hsuan wei Huang
NTNi-Chin Tsai
Ni-Chin Tsai
LJLin Yu Ju
Lin Yu Ju
HLHao-Ting Lien
Hao-Ting Lien
KLKuo-Chung Lan
Kuo-Chung Lan
Background/Objectives: MicroRNAs released into spent culture medium (SCM) may reflect embryo developmental status, but their relationship with blastocyst morphology and time-lapse morphokinetic behavior remains incompletely understood. This prospective study aimed to investigate whether selected SCM microRNAs are associated with blastocyst morphological grade and early morphokinetic dynamics in human embryos. Methods: A total of 432 SCM samples were collected from embryos cultured in a time-lapse incubation system between October 2018 and July 2020. Blastocysts were classified as good, fair, or poor quality according to morphological grading. The expression levels of six candidate microRNAs, including miR-182-5p, miR-302a-3p, miR-372-3p, miR-373-3p, miR-518a-3p, and miR-519d-3p, were quantified using real-time quantitative polymerase chain reaction. Associations between microRNA expression, embryo morphology, and morphokinetic parameters were analyzed using GEE, multivariate logistic regression, and receiver operating characteristic (ROC) analysis. Results: After accounting for within-patient clustering using GEE, good-quality embryos showed significantly lower expression of miR-372-3p and miR-373-3p than poor-quality embryos. On multivariate logistic regression, lower miR-372-3p expression remained independently associated with optimal t5–t2 interval after adjustment, whereas its associations with optimal CC3 and the combined outcomes were attenuated. ROC analysis demonstrated modest discriminatory ability for miR-372-3p alone (AUC = 0.644), whereas embryo morphology alone achieved an AUC of 0.731, and the combined model incorporating morphology and miR-372-3p reached the highest AUC of 0.752. Conclusions: These findings suggest that SCM microRNA expression is associated with embryo development. In particular, reduced miR-372-3p expression may reflect more favorable blastocyst morphology and early developmental dynamics, supporting its potential as an adjunctive molecular indicator of embryo quality. Further validation incorporating embryo ploidy status and clinical outcomes is warranted before clinical application.